Healthcare / Medical Care FacilitiesSaudi
$21.30
-0.10 (-0.47%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 18%
FCF escenarios
weak_data · normalized FCF $3.9M · quality 37.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
44/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$426M
P/E
14.8x
↓EV/EBITDA
8.4x
↓ROE
6.5%
↑Gross Margin
23.1%
↓Debt/Equity
0.92
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+9.4%
FCF CAGR
—
FCF margin
-0.2%
FCF / Net income
-0.09x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $842.2M · net income $23.6M · FCF $-2.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $842.2M | $842.2M | $739.3M | $806.9M | $642.7M |
| Net Income | $23.6M | $23.6M | $-66.6M | $38.1M | $20.5M |
| EBITDA | $89.9M | $89.9M | $3.5M | $105.4M | $65.1M |
| EPS | — | — | -3.37 | 1.92 | 1.02 |
| Gross Margin | 23.1% | 23.1% | 23.3% | 23.6% | 24.0% |
| Operating Margin | 7.8% | 7.8% | 7.3% | 6.6% | 6.3% |
| Net Margin | 2.8% | 2.8% | -9.0% | 4.7% | 3.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.92 | 0.92 | 2.00 | 1.66 | 1.62 |
| Current Ratio | 1.47 | 1.47 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-2.1M | $-2.1M | $101.0M | $3.9M | $53.8M |
| Returns | |||||
| ROE | 6.5% | 6.5% | -27.3% | 12.4% | 7.1% |
| Valuation | |||||
| P/E | 14.79 | 14.79 | — | 20.70 | 40.15 |
| EV/EBITDA | 8.39 | 8.39 | 340.77 | 11.53 | 18.51 |
| P/B | 1.15 | 1.15 | 3.24 | 2.57 | 2.82 |
| Growth & Yield | |||||
| Revenue Growth | 13.9% | 13.9% | -8.4% | 25.6% | — |
| EPS Growth | — | — | -275.5% | 88.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-28.8%
Start / end P/E
n/dx → n/dx
EPS bridge
-3.37 → n/d
Residual
-28.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.